“…Therefore, it is proposed that a drug delivery system that can transport DOX to the tumor site should be developed to achieve better antitumor effect and reduce adverse reactions. Due to the advantages that traditional delivery systems do not have, nano-drug delivery systems have been widely studied as drug carriers, and many nano-drug delivery systems have been developed, such as magnetic nanoparticles ( Hosseinpour Moghadam et al, 2019 ), microemulsion ( Lv et al, 2018 ; Wang et al, 2019 ), liposomes ( Antimisiaris et al, 2021 ), gold nanoparticles ( Lochbaum et al, 2021 ), platinum nanoparticles ( Kawawaki et al, 2021 ), polymer micelles ( Yang et al, 2021 ), etc. In these drug delivery systems, polymeric micelles are considered to be effective nanocarriers because they can encapsulate hydrophobic agents into their “core-shell” structures and deliver them to tumor regions through enhanced permeability and retention (EPR) effect.…”